Shinji Hadano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shinji Hadano has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Asako Otomo
Molecular Neuropathobiology Laboratory, Department of Molecular Life Sciences, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan; Micro/Nano Technology Center, Tokai University, Hiratsuka, Kanagawa, 259-1292, Japan
16 shared publications Shun Mitsui
Tokai Univ, Dept Mol Life Sci, Mol Neuropathobiol Lab, Sch Med, Isehara, Kanagawa 2591193, Japan
8 shared publicationsAsako Otomo
Molecular Neuropathobiology Laboratory, Department of Physiology Tokai University School of Medicine Isehara Kanagawa Japan
7 shared publicationsKai Sato
Tokai Univ, Dept Mol Life Sci, Mol Neuropathobiol Lab, Sch Med, Isehara, Kanagawa 2591193, Japan
7 shared publicationsSuzuka Ono
Tokai Univ, Dept Mol Life Sci, Mol Neuropathobiol Lab, Sch Med, Isehara, Kanagawa 2591193, Japan
7 shared publicationsHui-Fang Shang
Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China
5 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wiley in Genes to Cells
- Vol. 31 (4) , e70134
The SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin‐Positive SQSTM1 Bodies
SQSTM1 is one of the causative genes of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The SQSTM1 protein regulates the degradation of polyubiquitinated proteins and autophagosome formation through its interaction with microtubule‐associated protein light chain 3 (MAP1LC3/LC3). However, the molecular mechanisms by which SQSTM1‐LC3 binding regulates the autophagy‐endolysosomal system (APELS) remain unclear. To elucidate the spatiotemporal role of SQSTM1, we transiently expressed wild‐type SQSTM1 or missense mutants carrying mutations in the LC3‐interacting region (LIR), fused with the photoconvertible fluorescent protein Dendra2. Live‐cell fluorescence imaging and co‐localization analyses with markers of the APELS were then performed. Particle analysis of photoconverted or non‐photoconverted SQSTM1‐positive structures in live cells revealed that the pathogenic L341V variant formed larger structures than the wild‐type. Co‐localization analyses further showed that both the L341V and artificial LIR3A mutants accumulated in large ubiquitin‐positive structures, likely due to impaired localization to autophagosomes. These results suggest that mutations within the LIR differentially affect autophagosome formation and cargo degradation within APELS‐related compartments, highlighting the importance of SQSTM1 structural integrity in ALS/FTD pathogenesis.
- 1 July 2026
- Published by Wiley in Genes to Cells
- Vol. 31 (4) , e70134
Open AccessThe SQSTM1 L341V Variant Associated With Sporadic ALS Promotes the Accumulation of Enlarged Ubiquitin‐Positive SQSTM1 Bodies
SQSTM1 is one of the causative genes of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The SQSTM1 protein regulates the degradation of polyubiquitinated proteins and autophagosome formation through its interaction with microtubule‐associated protein light chain 3 (MAP1LC3/LC3). However, the molecular mechanisms by which SQSTM1‐LC3 binding regulates the autophagy‐endolysosomal system (APELS) remain unclear. To elucidate the spatiotemporal role of SQSTM1, we transiently expressed wild‐type SQSTM1 or missense mutants carrying mutations in the LC3‐interacting region (LIR), fused with the photoconvertible fluorescent protein Dendra2. Live‐cell fluorescence imaging and co‐localization analyses with markers of the APELS were then performed. Particle analysis of photoconverted or non‐photoconverted SQSTM1‐positive structures in live cells revealed that the pathogenic L341V variant formed larger structures than the wild‐type. Co‐localization analyses further showed that both the L341V and artificial LIR3A mutants accumulated in large ubiquitin‐positive structures, likely due to impaired localization to autophagosomes. These results suggest that mutations within the LIR differentially affect autophagosome formation and cargo degradation within APELS‐related compartments, highlighting the importance of SQSTM1 structural integrity in ALS/FTD pathogenesis.
- Open Access
- 3 February 2025
- Published by Elsevier in Current Research in Food Science
- Vol. 10, 100993
Soymilk yogurt prepared using Pediococcus pentosaceus TOKAI 759m ameliorates cognitive function through gut microbiota modulation in high-fat diet mice
- 3 February 2025
- Published by Elsevier in Current Research in Food Science
- Vol. 10, 100993
Open AccessSoymilk yogurt prepared using Pediococcus pentosaceus TOKAI 759m ameliorates cognitive function through gut microbiota modulation in high-fat diet mice
- Open Access
- 8 February 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (3) , pgae060
Effect of PCDH19 missense mutations on cell-to-cell proximity and neuronal development under heterotypic conditions
The mutation of the X-linked protocadherin (PCDH) 19 gene in heterozygous females causes epilepsy. However, because of the erosion of X-chromosome inactivation (XCI) in female human pluripotent stem cells, precise disease modeling often leads to failure. In this study, using a mathematical approach and induced pluripotent stem cells retaining XCI derived from patients with PCDH19 missense mutations, we found that heterotypic conditions, which are composed of wild-type and missense PCDH19, led to significant cell-to-cell proximity and impaired neuronal differentiation, accompanied by the aberrant accumulation of doublecortin, a microtubule-associated protein. Our findings suggest that ease of adhesion between cells expressing either wild-type or missense PCDH19 might lead to aberrant cell aggregation in early embryonic phases, causing poor neuronal development.
- 8 February 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (3) , pgae060
Open AccessEffect of PCDH19 missense mutations on cell-to-cell proximity and neuronal development under heterotypic conditions
The mutation of the X-linked protocadherin (PCDH) 19 gene in heterozygous females causes epilepsy. However, because of the erosion of X-chromosome inactivation (XCI) in female human pluripotent stem cells, precise disease modeling often leads to failure. In this study, using a mathematical approach and induced pluripotent stem cells retaining XCI derived from patients with PCDH19 missense mutations, we found that heterotypic conditions, which are composed of wild-type and missense PCDH19, led to significant cell-to-cell proximity and impaired neuronal differentiation, accompanied by the aberrant accumulation of doublecortin, a microtubule-associated protein. Our findings suggest that ease of adhesion between cells expressing either wild-type or missense PCDH19 might lead to aberrant cell aggregation in early embryonic phases, causing poor neuronal development.
- Open Access
- 22 November 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 638, 168-175
Central nervous system specific high molecular weight ALS2/alsin homophilic complex is enriched in mouse brain synaptosomes
- 22 November 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 638, 168-175
Open AccessCentral nervous system specific high molecular weight ALS2/alsin homophilic complex is enriched in mouse brain synaptosomes
- Open Access
Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies
Infantile onset hereditary spastic paralysis (IAHSP) is a rare neurological disease diagnosed in less than 50 children worldwide. It is transmitted with a recessive pattern and originates from mutations of the ALS2 gene, encoding for the protein alsin and involved in differentiation and maintenance of the upper motoneuron. The exact pathogenic mechanisms of IAHSP and other neurodevelopmental diseases are still largely unknown. However, previous studies revealed that, in the cytosolic compartment, alsin is present as an active tetramer, first assembled from dimer pairs. The C-terminal VPS9 domain is a key interaction site for alsin dimerization. Here, we present an innovative drug discovery strategy, which identified a drug candidate to potentially treat a patient harboring two ALS2 mutations: one truncation at lysine 1457 (not considered) and the substitution of arginine 1611 with a tryptophan (R1611W) in the C-terminus VPS9. With a protein modeling approach, we obtained a R1611W mutant model and characterized the impact of the mutation on the stability and flexibility of VPS9. Furthermore, we showed how arginine 1611 is essential for alsin’s homo-dimerization and how, when mutated to tryptophan, it leads to an abnormal dimerization pattern, disrupting the formation of active tetramers. Finally, we performed a virtual screening, individuating an already therapy-approved compound (MK4) able to mask the mutant residue and re-establishing the alsin tetramers in HeLa cells. MK4 has now been approved for compassionate use.
Open AccessPersonalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies
Infantile onset hereditary spastic paralysis (IAHSP) is a rare neurological disease diagnosed in less than 50 children worldwide. It is transmitted with a recessive pattern and originates from mutations of the ALS2 gene, encoding for the protein alsin and involved in differentiation and maintenance of the upper motoneuron. The exact pathogenic mechanisms of IAHSP and other neurodevelopmental diseases are still largely unknown. However, previous studies revealed that, in the cytosolic compartment, alsin is present as an active tetramer, first assembled from dimer pairs. The C-terminal VPS9 domain is a key interaction site for alsin dimerization. Here, we present an innovative drug discovery strategy, which identified a drug candidate to potentially treat a patient harboring two ALS2 mutations: one truncation at lysine 1457 (not considered) and the substitution of arginine 1611 with a tryptophan (R1611W) in the C-terminus VPS9. With a protein modeling approach, we obtained a R1611W mutant model and characterized the impact of the mutation on the stability and flexibility of VPS9. Furthermore, we showed how arginine 1611 is essential for alsin’s homo-dimerization and how, when mutated to tryptophan, it leads to an abnormal dimerization pattern, disrupting the formation of active tetramers. Finally, we performed a virtual screening, individuating an already therapy-approved compound (MK4) able to mask the mutant residue and re-establishing the alsin tetramers in HeLa cells. MK4 has now been approved for compassionate use.
- Open Access
- 28 May 2022
- Published by Elsevier in Neurochemistry International
- Vol. 158, 105364
SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron
- 28 May 2022
- Published by Elsevier in Neurochemistry International
- Vol. 158, 105364
Open AccessSQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron
- Open Access
- 1 January 2022
- Published by Elsevier in Neuroscience Research
- Vol. 174, 46-52
High-throughput quantitative analysis of axonal transport in cultured neurons from SOD1H46R ALS mice by using a microfluidic device
- 1 January 2022
- Published by Elsevier in Neuroscience Research
- Vol. 174, 46-52
Open AccessHigh-throughput quantitative analysis of axonal transport in cultured neurons from SOD1H46R ALS mice by using a microfluidic device
- 1 September 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 569, 106-111
The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2
- 1 September 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 569, 106-111
The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2
- Open Access
- 1 March 2021
- Published by Elsevier in eNeurologicalSci
- Vol. 22, 100301
SQSTM1L341V variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells
- 1 March 2021
- Published by Elsevier in eNeurologicalSci
- Vol. 22, 100301
Open AccessSQSTM1L341V variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells